Skip to main content

Find Clinical Trials

Home
Conditions
AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2

Clinical trial condition

AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2

Explore clinical trials studying AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2 trial results

Recruiting

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

NCT06092346

Conditions: ADA2 protein, human, ADA2, OMIM *607575,Sneddon Syndrome; VAIHS, ADSL, OMIM *608222, Adenylosuccinate Lyase Deficiency, +84 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details